These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27490456)

  • 1. Spironolactone nanocrystals for oral administration: Different pharmacokinetic performances induced by stabilizers.
    Mu S; Li M; Guo M; Yang W; Wang Y; Li J; Fu Q; He Z
    Colloids Surf B Biointerfaces; 2016 Nov; 147():73-80. PubMed ID: 27490456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro and in-vivo study of amorphous spironolactone prepared by adsorption method using supercritical CO2.
    Jiang Q; Li Y; Fu Q; Geng Y; Zhao J; Ma P; Zhang T
    Drug Dev Ind Pharm; 2015 Feb; 41(2):201-6. PubMed ID: 24369091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and Evaluation of Diosgenin Nanocrystals to Improve Oral Bioavailability.
    Liu CZ; Chang JH; Zhang L; Xue HF; Liu XG; Liu P; Fu Q
    AAPS PharmSciTech; 2017 Aug; 18(6):2067-2076. PubMed ID: 27995466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability.
    Khan MA; Ansari MM; Arif ST; Raza A; Choi HI; Lim CW; Noh HY; Noh JS; Akram S; Nawaz HA; Ammad M; Alamro AA; Alghamdi AA; Kim JK; Zeb A
    Drug Deliv; 2021 Dec; 28(1):2510-2524. PubMed ID: 34842018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes.
    Chen M; Li W; Zhang X; Dong Y; Hua Y; Zhang H; Gao J; Zhao L; Li Y; Zheng A
    Int J Nanomedicine; 2017; 12():5487-5500. PubMed ID: 28814865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of nimodipine nanocrystals for oral administration.
    Li J; Fu Q; Liu X; Li M; Wang Y
    Arch Pharm Res; 2016 Feb; 39(2):202-212. PubMed ID: 26584914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
    Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
    Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Evaluation of Meloxicam Nanocrystals by Oral Administration with Different Particle Sizes.
    Yu Y; Tian Y; Zhang H; Jia Q; Chen X; Kang D; Du Y; Song S; Zheng A
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of effective stabilizers in improving oral bioavailability of naringenin nanocrystals: Maintenance of supersaturation generated upon dissolution by inhibition of drug dimerization.
    Zhang G; Guan H; Li J; Li M; Sui X; Tian B; Dong H; Liu B; He Z; Li N; Zhao M; Fu Q
    Asian J Pharm Sci; 2022 Aug; 17(5):741-750. PubMed ID: 36382308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quercetin nanocrystals for bioavailability enhancement: impact of different functional stabilizers on
    Zhu Y; Hu F; Shen C; Shen B; Yuan H
    Pharm Dev Technol; 2024 Jun; ():1-8. PubMed ID: 38808380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical and pharmacokinetic characteristics of different types of fenofibrate nanocrystals prepared by different bottom-up approaches.
    Zhang H; Meng Y; Wang X; Dai W; Wang X; Zhang Q
    Drug Deliv; 2014 Dec; 21(8):588-94. PubMed ID: 24320001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement.
    Zhang J; Huang Y; Liu D; Gao Y; Qian S
    Eur J Pharm Sci; 2013 Mar; 48(4-5):740-7. PubMed ID: 23305994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Water-soluble beta-cyclodextrins in paediatric oral solutions of spironolactone: preclinical evaluation of spironolactone bioavailability from solutions of beta-cyclodextrin derivatives in rats.
    Kaukonen AM; Lennernäs H; Mannermaa JP
    J Pharm Pharmacol; 1998 Jun; 50(6):611-9. PubMed ID: 9680070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of salt formation between memantine and pamoic acid: Its exploitation in nanocrystalline form as long acting injection.
    Mittapelly N; Rachumallu R; Pandey G; Sharma S; Arya A; Bhatta RS; Mishra PR
    Eur J Pharm Biopharm; 2016 Apr; 101():62-71. PubMed ID: 26850817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in-vitro/in-vivo characterization of trans-resveratrol nanocrystals for oral administration.
    Singh SK; Makadia V; Sharma S; Rashid M; Shahi S; Mishra PR; Wahajuddin M; Gayen JR
    Drug Deliv Transl Res; 2017 Jun; 7(3):395-407. PubMed ID: 28194730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilizer-induced different in vivo behaviors for intramuscularly long-acting celecoxib nanocrystals.
    Qin M; Xin J; Han W; Li M; Sui X; Dong H; Fu Q; He Z
    Int J Pharm; 2022 Nov; 628():122298. PubMed ID: 36257466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation.
    Jiang T; Han N; Zhao B; Xie Y; Wang S
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1230-9. PubMed ID: 22229827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursolic Acid Nanocrystals for Dissolution Rate and Bioavailability Enhancement: Influence of Different Particle Size.
    Pi J; Liu Z; Wang H; Gu X; Wang S; Zhang B; Luan H; Zhu Z
    Curr Drug Deliv; 2016; 13(8):1358-1366. PubMed ID: 26953239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine.
    Xiong W; Sang W; Linghu KG; Zhong ZF; Cheang WS; Li J; Hu YJ; Yu H; Wang YT
    Int J Nanomedicine; 2018; 13():3781-3793. PubMed ID: 29988733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo.
    Tuomela A; Liu P; Puranen J; Rönkkö S; Laaksonen T; Kalesnykas G; Oksala O; Ilkka J; Laru J; Järvinen K; Hirvonen J; Peltonen L
    Int J Pharm; 2014 Jun; 467(1-2):34-41. PubMed ID: 24680962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.